CHAPTER 207
An Act to direct the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling.
[H 712]
Approved April 6, 2026
Be it enacted by the General Assembly of Virginia:
1. § 1. That the Board of Medicine shall amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. Under such regulations, a patient's refusal shall not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder.